Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Additionally, the final follow-up indicated no significant variation in the rates of excellent and good outcomes, suggesting that the initial therapeutic advantage conferred by dexamethasone and VB12 did not translate into superior long-term outcomes
Now serving beta test users in: MA, NY, and FL (CA soon, and waitlist open for all other states) Learn more: Questions: [email protected] or [email protected] (POM = Peace of Mind, which everyone deserves when it comes to cancer) Thanks also to our first investor Leo Korsunsky
These improved biomarkers correspond with endpoints such as improved gait and body composition
Are postpartum and medically cleared for weight loss efforts with fatigue or nutritional depletion
We took it by mouth
Consulting with a healthcare provider for a thorough evaluation is often the first step in personalizing treatment
